In MS and SLE patients, Abzs against myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP) possessing protease activity may attack proteins of the myelin–proteolipid sheath of axons. This evidence concerns the gene MBP and myeloid sarcoma.